Banner

Integration Of Glycolytic Metabolic Marker (GLUT1) And CD147 Expression In Progression Of Prostatic Carcinoma;An immuohistochemical study

Med. J. Cairo Univ • 2017
Back
Publication Information
Authors Marwa Said Abd Allah1 and Omneya Yossef Bassyoni1
Keywords GLUT1, CD147, Prostatic Carcinoma. GLUT1, CD147,prostatic carcinoma
Journal Med. J. Cairo Univ
Publisher Not Available
Volume Vol. 85
Issue No. 7
Pages 2591-2599
publication.type Local
Paper Link Not Available
Supplementary Materials Not Available
Abstract
Background: Increased glycolysis has been considered one of the characteristic features of cancer.Glucose transporter 1 (GLUT1) plays a central role in the transport of glucose in tumor cells. CD147 is multifunctional glycoprotein overexpressed in many solids tumors.
Methods: This is a retrospective controlled study on 46 cases of prostatic carcinoma to recognize the expression of GLUT1 and CD147 by immunohistochemistry and to identify their correlation with different clinicopathological parameters.
Results: GLUT1 and CD147 positive expression was detected in 25/46 (54.3%) and 29/46 (63.0%) of prostatic carcinoma, respectively. GLUT1 and CD147 expression was significantly higher in prostatic carcinoma than BPH and HGPIN. Significant positive correlation between GLUT1 and CD147 immunoreactivity in prostatic carcinoma was seen. Positive GLUT1 expression was statistically correlated with high Gleason score (P